Micronucleus induction in V79 cells by the anabolic doping steroids desoxymethyltestosterone (madol) and 19-norandrostenedione

Toxicology Letters

Volumn 183, Issue 1-3, 2008, Pages 58-64

  Dorn, Susanne B ^a   Bolt, Hermann M ^a   Thevis, Mario ^b   Diel, Patrick ^b   Degen, Gisela H ^a  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

19 Norandrostenedione; Anabolic steroids; Doping; Genotoxicity; Madol; Micronucleus assay

Indexed keywords

DESOXYMETHYLTESTOSTERONE; ESTR 4 ENE 3,17 DIONE; REACTIVE OXYGEN METABOLITE; TESTOSTERONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL STRAIN V 79; CENTROMERE; CHROMOSOME DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; GENOTOXICITY; LIPOPHILICITY; MICRONUCLEUS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL;

ANABOLIC AGENTS; ANDROSTENEDIONE; ANDROSTENOLS; ANIMALS; APOPTOSIS; CAMPTOTHECIN; CELL DIVISION; CELL LINE; DOPING IN SPORTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; G2 PHASE; HYDROGEN PEROXIDE; METHYL METHANESULFONATE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MICROSCOPY, FLUORESCENCE; MOLECULAR STRUCTURE; MUTAGENS; REACTIVE OXYGEN SPECIES; S PHASE;

EID: 56549128556     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.09.016     Document Type: Article

References (47)

1. Anonymous. Scientific report on anabolic agents in animal production. Scientific Working Group on Anabolic Agents. Vet. Rec. 127 (1987) 389-392
2. Bonacker D., Stoiber T., Böhm K.J., Unger E., Degen G.H., Thier R., and Bolt H.M. Chromosomal genotoxicity of nitrobenzene and benzonitrile. Arch. Toxicol. 78 (2004) 49-57
3. Bradley M.O., Taylor V.I., Armstrong M.J., and Galloway S.M. Relationships among cytotoxicity, lysosomal breakdown, chromosome aberrations, and DNA double-strand breaks. Mutat Res 189 (1987) 69-79
4. Catlin D.H., Ahrens B.D., and Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. Rapid Commun. Mass Spectrom. 16 (2002) 1273-1275
5. Catlin D.H., Sekera M.H., Ahrens B.D., Starcevic B., Chang Y.C., and Hatton C.K. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun. Mass Spectrom. 18 (2004) 1245-1249
6. Countryman P.I., and Heddle J.A. The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat. Res. 41 (1976) 321-332
7. De Clerck L.S., Bridts C.H., Mertens A.M., Moens M.M., and Stevens W.J. Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function. J. Immunol. Methods 172 (1994) 115-124
8. De Cock K.J., Delbeke F.T., Van Eenoo P., Desmet N., Roels K., and De Backer P. Detection and determination of anabolic steroids in nutritional supplements. J. Pharm. Biomed. Anal. 25 (2001) 843-852
9. Deftos L.J. Games of hormones: the para-endocrinology of sport. Endocr. Pract. 12 (2006) 472-474
10. Dehennin L., Bonnaire Y., and Plou P. Human nutritional supplements in the horse: comparative effects of 19-norandrostenedione and 19-norandrostenediol on the 19-norsteroid profile and consequences for doping control. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 766 (2002) 257-263
11. Diel P., Friedel A., Geyer H., Kamber M., Laudenbach-Leschowsky U., Schanzer W., Schleipen B., Thevis M., Vollmer G., and Zierau O. The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration. Toxicol. Lett. 177 (2008) 198-204
12. Diel P., Friedel A., Geyer H., Kamber M., Laudenbach-Leschowsky U., Schanzer W., Thevis M., Vollmer G., and Zierau O. Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping. Toxicol. Lett. 169 (2007) 64-71
13. Dolezel J., Binarova P., and Lucetti S. Analysis of nuclear DNA content in plant cells by flow cytometry. Biol. Plant. 31 (1989) 113-121
14. Dorn S.B., Bolt H.M., Thevis M., Diel P., and Degen G.H. Induction of micronuclei in V79 cells by the anabolic doping steroids tetrahydrogestrinone and trenbolone. Arch. Toxicol. 82 (2008) 257-263
15. Dorn S.B., Degen G.H., Bolt H.M., van der L.J., van Acker F.A., van den Dobbelsteen D.J., and Lommerse J.P. Some molecular descriptors for non-specific chromosomal genotoxicity based on hydrophobic interactions. Arch. Toxicol. 82 (2008) 333-338
16. Dorn S.B., Degen G.H., Müller T., Bonacker D., Joosten H.F., van der Louw J., van Acker F.A.A., and Bolt H.M. Proposed criteria for specific and non-specific chromosomal genotoxicity based on hydrophobic interactions. Mutat. Res. 628 (2007) 67-75
17. Friedel A., Geyer H., Kamber M., Laudenbach-Leschowsky U., Schänzer W., Thevis M., Vollmer G., Zierau O., and Diel P. Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver. Toxicol. Lett. 164 (2006) 16-23
18. Galloway S., Miller J.E., Armstrong M.J., Bean C.L., Skopek T.R., and Nichols W.W. DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens. Mutat Res 400 (1998) 169-186
19. Goegan P., Johnson G., and Vincent R. Effects of serum protein and colloid on the alamarBlue assay in cell cultures. Toxicol. In Vitro 9 (1995) 257-266
20. Joosten H.F., van Acker F.A., van den Dobbelsteen D.J., Horbach G.J., and Krajnc E.I. Genotoxicity of hormonal steroids. Toxicol Lett 151 (2004) 113-134
21. Kincl F.A., and Dorfman R.I. Anabolic-androgenic potency of various steroids in a castrated rat assay. Steroids 3 (1964) 109-122
22. Kirkland D., Aardema M., Henderson L., and Müller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat. Res. 584 (2005) 1-256
23. Kirkland D., Pfuhler S., Tweats D., Aardema M., Corvi R., Darroudi F., Elhajouji A., Glatt H., Hastwell P., Hayashi M., Kasper P., Kirchner S., Lynch A., Marzin D., Maurici D., Meunier J.R., Müller L., Nohynek G., Parry J., Parry E., Thybaud V., Tice R., van Benthem J., Vanparys P., and White P. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutat. Res. 628 (2007) 31-55
24. Kirkland D.J., Hayashi M., MacGregor J.T., Müller L., Schechtman L., and Sofuni T. Summary of major conclusions from the International Workshop on Genotoxicity Test Procedures. Environ. Mol. Mutagen. 35 (2000) 162-166
25. Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66 (1975) 188-193
26. Lorge E., Lambert C., Gervais V., Becourt-Lhote N., Delongeas J.L., and Claude N. Genetic toxicity assessment: employing the best science for human safety evaluation. Part II. Performances of the in vitro micronucleus test compared to the mouse lymphoma assay and the in vitro chromosome aberration assay. Toxicol. Sci. 96 (2007) 214-217
27. Lorge E., Thybaud V., Aardema M.J., Oliver J., Wakata A., Lorenzon G., and Marzin D. SFTG international collaborative study on in vitro micronucleus test. I. General conditions and overall conclusions of the study. Mutat. Res. 607 (2006) 13-36
28. Matsuoka A., Yamazaki N., Suzuki T., Hayashi M., and Sofuni T. Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutat. Res. 272 (1992) 223-236
29. Meintières S., Biola A., Pallardy M., and Marzin D. Apoptosis can be a confusing factor in in vitro clastogenic assays. Mutagenesis 16 (2001) 243-250
30. Meintières S., and Marzin D. Apoptosis may contribute to false-positive results in the in vitro micronucleus test performed in extreme osmolality, ionic strength and pH conditions. Mutat. Res. 560 (2004) 101-118
31. Miller B.M., and Adler I.D. Application of antikinetochore antibody staining (CREST staining) to micronuclei in erythrocytes induced in vivo. Mutagenesis 5 (1990) 411-415
32. Nociari M.M., Shalev A., Benias P., and Russo C. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J. Immunol. Methods 213 (1998) 157-167
33. O'Brien J., Wilson I., Orton T., and Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267 (2000) 5421-5426
34. Parr M.K., Geyer H., Reinhart U., and Schanzer W. Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements. Food Addit. Contam. 21 (2004) 632-640
35. Pratt I.S., and Barron T. Regulatory recognition of indirect genotoxicity mechanisms in the European Union. Toxicol. Lett. 140-141 (2003) 53-62
36. Renzi L., Pacchierotti F., and Russo A. The centromere as a target for the induction of chromosome damage in resting and proliferating mammalian cells: assessment of mitomycin C-induced genetic damage at kinetochores and centromeres by a micronucleus test in mouse splenocytes. Mutagenesis 11 (1996) 133-138
37. Rosenkranz A.R., Schmaldienst S., Stuhlmeier K.M., Chen W., Knapp W., and Zlabinger G.J. A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate. J. Immunol. Methods 156 (1992) 39-45
38. Russo A., Stocco A., Renzi L., Bianco N., and Majone F. Persistence of chromosomal lesions induced in actively proliferating bone marrow cells of the mouse. Mutat. Res. 269 (1992) 119-127
39. Schrader Y., Thevis M., and Schanzer W. Quantitative determination of metabolic products of 19-norandrostenediol in human plasma using gas chromatography/mass spectrometry. Drug Metab. Dispos. 34 (2006) 1328-1335
40. Schuler M., Rupa D.S., and Eastmond D.A. A critical evaluation of centromeric labeling to distinguish micronuclei induced by chromosomal loss and breakage in vitro. Mutat. Res. 392 (1997) 81-95
41. Schultz N., and Önfelt A. Sensitivity of cytokinesis to hydrophobic interactions. Chemical induction of bi-and multinucleated cells. Chem. Biol. Interact. 126 (2000) 97-123
42. Scott D., Galloway S.M., Marshall R.R., Ishidate Jr. M., Brusick D., Ashby J., and Myhr B.C. International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9. Mutat. Res. 257 (1991) 147-205
43. Sekera M.H., Ahrens B.D., Chang Y.C., Starcevic B., Georgakopoulos C., and Catlin D.H. Another designer steroid: discovery, synthesis, and detection of 'madol' in urine. Rapid Commun. Mass Spectrom. 19 (2005) 781-784
44. Stoiber T., Unger E., Dorn S.B., Degen G.H., and Bolt H.M. Hydrophobic interaction of organic chemicals with microtubule assembly in vitro. Arch. Toxicol. 82 (2008) 601-606
45. Uralets V.P., and Gillette P.A. Over-the-counter anabolic steroids 4-androsten-3,17-dione; 4-androsten-3beta,17beta-diol; and 19-nor-4-androsten-3,17-dione: excretion studies in men. J. Anal. Toxicol. 23 (1999) 357-366
46. von der Hude W., Kalweit S., Engelhardt G., McKiernan S., Kasper P., Slacik-Erben R., Miltenburger H.G., Honarvar N., Fahrig R., Gorlitz B., Albertini S., Kirchner S., Utesch D., Potter-Locher F., Stopper H., and Madle S. In vitro micronucleus assay with Chinese hamster V79 cells-results of a collaborative study with in situ exposure to 26 chemical substances. Mutat. Res. 468 (2000) 137-163
47. WHO. JECFA and Joint FAO/WHO Expert Committee on Food Additives: toxicological evaluation of certain veterinary drug residues in food. WHO Food Addit. Ser. 23 (1988) 123-151